alexa The Analysis of Yellow Fever Virus Antigen in Human Serum from Epidemic Areas of Tianjin Port, 2012 | OMICS International
ISSN: 2332-0877
Journal of Infectious Diseases & Therapy
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

The Analysis of Yellow Fever Virus Antigen in Human Serum from Epidemic Areas of Tianjin Port, 2012

Jun Qi1, Guolei Li2 and Guoyu N2*

1Tianjin International Travel Health Care Center, Tianjin, 300456, P.R. China

2School of Public Health, WeiFang Medical University, 261053, China

*Corresponding Author:
Guoyu N
School of Public Health, WeiFang Medical University
261053, China
E-mail: [email protected]

Received date: April 27, 2017; Accepted date: May 22, 2017; Published date: May 29, 2017

Citation: Jun Qi, Guolei Li, Guoyu N (2017) The Analysis of Yellow Fever Virus Antigen in Human Serum from Epidemic Areas of Tianjin Port, 2012. J Infect Dis Ther 5:320. doi:10.4172/2332-0877.1000320

Copyright: © 2017 Guoyu N. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Infectious Diseases & Therapy

Abstract

Objective: To investigate the prevalence and distribution characteristics of yellow fever virus (YFV) antigen in human serum from epidemic areas of Tianjin port in 2012.

Methods: The people from the yellow fever epidemic areas of Tianjin port were selected as study object. 172 samples were collected together with detailed personal information. And each sample contained 5 ml venous blood. Indirect ELISA was used to detect YFV antigen. The dengue virus antigen and west nile virus antigen were also detected in positive samples to reduced cross reactivity. Positive rate was calculated. Statistical methods were used to compare the differences of the positive rates between different countries, genders, ages, occupations and entry time.

Results: All respondents came from Africa and South America. The total positive rate of serum antigen of YFV was 11.63% (20/172). Of which, the positive rates of African and South American people were 10.96% and 15.38%, respectively. The positive rates of male and female were 11.68% and 11.43%, respectively. The positive rate of >40 year old age group was the highest, up to 17.24%. In the time distribution, the positive rate of third-quarter entry personnel was up to 14.94%. There was no significant difference in positive rate between different countries, genders, ages, and entry time, except occupations. Workers engaged in labor service positive rate was 29.41%.

Conclusion: The YFV antigen positive rate of people from epidemic areas in 2012 was high. These people carrying pathogens pose a threat to public health security of China as a potential source of infection. There was a significant difference in the detection rate of YFV antibody among people with different occupations.

Keywords

Tianjin port; Yellow fever virus; Antigen detection

Fund program

Natural Science Foundation in Shandong Province (ZR2016CL03).

Introduction

Yellow fever (YF) is an acute infectious disease caused by yellow fever virus (YFV), which is one of the three infectious diseases of international health regulations [1]. YFV belongs to flavivirus, transmitted through the medium of mosquito among vertebrates [2]. As molecular epidemiological data shown, YFV has seven genotypes distribution geographically and it associates with a specific genotype in one outbreak [3]. YFV infection has Jungle type and city type. The type of the jungle is transmitted in the form of monkey-mosquito-monkey [4]. However, human is the main source of city type. The main clinical symptoms are fever, jaundice, hemorrhage and proteinuria, 5% to 20% of patients manifested clinical symptoms, a small number of patients came to severe case and death [5]. No specific treatment for YF is available at present, symptomatic treatment is used generally. Both of 17D vaccine strain produced by chicken embryo tissue culture Asibi strain and virulent strain of vaccine (FNV) prepared from rat brain culture of a strain of France can reduce the incidence of yellow fever significantly. FNV has been disabled because it can cause the nerve disease, but 17D vaccine strain is still used today [6]. According to WHO, there are at least 200 thousand cases of YF in the world each year, and 30 thousand people lose their lives. Yellow fever poses a serious threat to human health [7]. YF is endemic in tropical regions of Africa and South America, but there may be cases of imported cases all over the world with the acceleration of global integration. At present, risk could not be ignored because international exchanges are increasingly frequent and the media of YFV exit in China. Beijing entry exit inspection and quarantine department confirmed the first case of imported YF cases on March 12, 2016, another 4 cases were found later. All five cases were returnees from Angola. Therefore, monitoring YF at the port is the key link in the whole epidemic prevention and control [8]. As a large industrial and commercial city in the North of China, Tianjin is not only a gateway of Beijing, but also an important channel for trade between North China and the world. In our study, YFV antigen screening was conducted to personnel from Africa and South America of Tianjin port in 2012. To analysis the popular features through observing the situation of people carrying YFV related antigen. According to the difference of antigen positive rate among different regions, gender, age, occupation and time, differentiate the key population to provide a basis for the prevention and detection of YF in Tianjin port.

Objects and Methods

1. Objects: Identify people of Tianjin port from Africa and South America as survey object, January 1, 2012 to December 31, 2012. 5 ml venous blood was collected and serum was gain through low speed centrifugation. Then the YFV antigen detection was conducted.

2. Methods: All samples were detected by Human Yellow fever virus antigen ELISA Kit (made by QIYI Shanghai Technology Co., Ltd.), which was used to detect the level of serum antigen by indirect ELISA. The dengue virus antibody and west nile virus antigen were also detected in positive samples to reduced cross reactivity. Human west nile virus antigen ELISA Kit (made by QIYI Shanghai Technology Co., Ltd.) was used to detect west nile virus antigen. And indirect ELISA method was utilized to detect dengue virus antigen. The antigen used in indirect ELISA was Dengue virus type1-4 E protein domain III fusion protein expressed in eukaryotic system (made by our department).

3. Quality control: Blood sampling and processing sites, operating process and preservation condition were strictly qualified. Standard blood collection tools were provided to guarantee the sampling. We repeated all the samples detection twice to verify the result, and repetition will stop only if the result of the two inspections is identical with each other.

4. Informed consent: Blood samples were all collected at International Travel health care center of Tianjin exit inspection and Quarantine Bureau, and all operations were strictly compliance with the provisions of the state on the entry of personnel management. Immigrants knew and agreed to collect serum, then had a physical examination.

5. Statistical analysis: Parallel the questionnaire using Epidata 3.2 software. After verification, import it into SAS 9.2 statistical software to make a statistical analysis.

Results

Basic situation

A total of 172 serum samples were collected from 38 countries of two continents. Of which, 146 samples were from 31 countries of Africa and 26 samples were from 7 countries of South America. In 38 countries, detection of YFV antigen in sera from 15 countries was positive, with total of 105 cases, and the positive rate 19.05%. And detection of YFV antigen in sera from 23 countries was negative, with total of 67 cases. As shown in Table 1.

Country Number Positive number Positive rate Country Number Positive number Positive rate
Egypt 6 2 33.33% Garner Nigeria 1 0 0
Ethiopia 8 1 12.50% Djibouti 2 0 0
Benin 2 1 50.00% Guinea 2 0 0
Somalia 1 1 100.00% Burundi 2 0 0
Ghana 8 1 12.50% Eritrea 2 0 0
Comoros 4 1 25.00% Congo 2 0 0
Mauritius 1 1 100.00% Gabon 1 0 0
Sierra leone 5 1 20.00% Zimbabwe 4 0 0
Seychelles 3 1 33.33% Cameroon 1 0 0
Tanzania 21 1 4.76% Lesotho 1 0 0
Tunisia 2 1 50.00% Mali 1 0 0
Uganda 11 2 18.18% South Africa 5 0 0
Zambia 18 1 5.56% Nigeria 11 0 0
Brazil 12 4 33.33% Sultan 8 0 0
Columbia 3 1 33.33% Algeria 1 0 0
        Kenya 3 0 0
        Madagascar 3 0 0
        Morocco 6 0 0
        Bolivia 1 0 0
        Peru 1 0 0
        Venezuela 3 0 0
        Chile 2 0 0
        Argentina 4 0 0
Total 117 20 17.09%   55 0 0

Table 1: The national distribution of yellow fever virus antigen detection.

The area distribution of YFV antigen detection

The YFV antigen detection rate in African was 10.96%, while that in South American was 15.38%. The YFV antigen detection rate of South American was higher than that of African, but the difference was not statistically significant (χ2=0.1, P=0.752). The YFV antigen was detected in people from 13 African counties out of 31, with 41.94% positive rate, and 2 South American countries out of 7, with 28.57% positive rate. Hence, there was also no significant difference in the detection rate of national distribution (χ2=0.051?P=0.822). As shown in Tables 1 and 2.

Feature Number Constituent ratio Positive number Positive rate
Area        
Africa 146 84.88% 16 10.96%
South America 26 15.12% 4 15.38%
x2 value       0.1
P value       0.752
National distribution        
Africa 31 81.58% 13 41.94%
South America 7 18.42% 2 28.57%
x2 value       0.051?
P value       0.822
Sex        
male 137 79.65% 16 11.68%
female 35 20.35% 4 11.43%
x2 value       0
P value       1
Age        
<20 12 6.98% 2 16.67%
20-30 49 28.49% 7 14.29%
30-40 82 47.67% 6 7.32%
>40 29 16.86% 5 17.24%
x2 value       3.006
P value       0.391
Occupation        
contract workers 17 9.88% 5 29.41%
students 91 52.91% 10 10.99%
Technical personnel 64 37.21% 5 7.81%
x2 value       6.175
P value       0.046
Time       0.289
First and second quarter 36 20.93% 2 5.56%
Third quarter 49 28.49% 5 10.20%
Fourth quarter 87 50.58% 13 14.94%
x2 value       3.68
P value       0.159
Total 172   20 11.63%

Table 2: The comparison of yellow fever virus antigen test results with different characteristics.

The gender distribution of YFV antigen detection

YFV antigen detection rate in male was 11.68%, while that in female was 11.43% among entry-personnel. However, there was no significant difference in detection rate (χ2=0?P=1), for details see attached Table 2.

The age distribution of YFV antigen detection

All respondents were divided into four groups, <20 age group, 20-30 age group, 30-40 age group and >40 age group. It was found that the positive rate of >40 age group was highest, up to 17.28%, the positive rate of 30-40 age group was lowest, up to 7.32% through comparing differences of YFV antigen detection rate among groups. And there was no significant difference in detection rate (χ2=3.006?P=0.391), for details see attached Table 2.

The occupation distribution of YFV antigen detection

The survey involved 3 categories of occupations, labor, students and technical personnel. It was found that the positive rate of labor was highest, up to 29.41%, the positive rate of technical personnel was lowest, up to 7.81% through comparing differences of YFV antigen detection rate among groups. And the detection rate was statistically significant differences (χ2=6.175?P=0.046), for details see attached Table 2.

The time distribution of YFV antigen detection

According to entry time, the samples were divided into four groups, the first quarter, the second quarter, the third quarter and the fourth quarter. As statistical results shown, the positive rate of the fourth quarter was highest, up to 14.94%, and there was no significant difference in the detection rate among other groups, for details see attached Table 2.

Discussion

YF is an acute infectious disease, which is one of the three major quarantine infectious diseases prescribed by the WHO and the frontier health and Quarantine Law of the People's Republic of China. And it is also the only infectious disease in the world that requires international vaccination [9]. At present, YF mainly exists in the form of endemic diseases in Africa and South America. However, with the deepening of the global economic integration process, the situation of rapid global spread of infectious diseases is becoming more and more serious. Besides, vector mosquitoes such as Aedes aegypti and Aedes albopictus are widely distributed in our country. Therefore, the risk of crossborder spread of the epidemic cannot be ignored [10]. Due to the lack of treatment effects of YF, YFV 17D vaccine injection is the most effective means of prevention of YF currently [11].

There are two mainly possibilities when the detection of YFV is positive. 1) People were infected with YFV recently. 2) People were infected with other similar flavivirus recently. It was reported that YFV and other arboviruses share partial antigen such as Dengue virus, West Nile virus [12,13]. In order to eliminate the influence of cross antigen, the YFV antigen-positive samples were detected for dengue virus and west Nile virus antigen. Based on the experimental results, 2 cases out of 20 were positive for dengue virus antigen. Because it has little effect on the results of epidemiological investigation, it is not included. Therefore, the result shows that the samples may be infected with YFV in the near past years, and it also can reflect the prevalence of local population.

Based on the result of area distribution of YFV antigen detection, the positive rates of Africa and South America were 10.96% and 15.38%, respectively, between which there was no statistical difference. It demonstrated that the two continents had different degrees of yellow fever virus natural infection, but the severity difference could not be distinguished. In the respect of country distribution, people from nearly 42% of African countries and 29% South American countries were detected positive. And no statistical difference was found. The YFV antigen detection rates of male and female were 11.68% and 11.43%, respectively. There was no statistical difference indicating that gender was not the influence factors of YFV infection, and this was also consistent with the epidemiological characteristics of other arbovirus infections. In terms of age distribution, the positive rate of >40 years group was the highest, 30-40 years old group was the lowest, but the difference was not statistically significant. It showed that age was not the influence factors of YFV infection. This was not consistent with the characteristics of infection of other arboviruses, and may be related to the sample bias. In general, the longer exposure in the viral cycle, the greater chance of being infected. Through collecting personal information our survey involved three occupations, of which the positive rate of contract workers was the highest, and there was significant difference between different occupations. Occupation is also an important factor in other arbovirus natural infection. People who are engaged in field work and outdoor physical work are more likely to be bitten by mosquitoes and be infected with YFV. This characteristic was similar with other arbovirus infections. In general, arbovirus infections were closely related to season and temperature. With the breeding of mosquitoes in the summer, the incidence of arbovirus infection increased significantly, but this feature is not obvious in tropical areas with little change in temperature. In our study, the positive rate of the fourth quarter was the highest but there was no statistical difference compared with the other quarters. It showed that the entry time was not the influencing factors in this investigation.

In summary, our investigation reveals that YFV infection is endemic in Africa and South America and the virus is also widely distributed in two continents. Therefore, the port quarantine officers need to take effective prevention and control measures to those who come from the quarantine area, such as increasing the intensity of vaccination certificate inspection. At present, there are some loopholes in the inspection of YFV vaccination certificate, and it is difficult to achieve the 100% inspection of people from the epidemic areas. According to the results of our study, occupation is the influence factors of detection of YFV antigen, which suggests that we should focus on the key population when conducting quarantine. Enhance the purpose of quarantine inspection, to achieve early detection, early diagnosis and early treatment and reduce the risk of yellow fever transmission [14].

Limitations of our study are obvious. Firstly, the subjects were brought into the survey passively rather than sampling actively. Hence, the results may not reflect all epidemiological features accurately. Secondly, the size of sample is too small. Data of several years are needed to obtain more accurate results. Thirdly, there are large differences in the composition of immigration personnel in each port. Therefore, the result of Tianjin port cannot be extrapolated to other ports.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 590
  • [From(publication date):
    June-2017 - Jul 18, 2018]
  • Breakdown by view type
  • HTML page views : 530
  • PDF downloads : 60
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7